<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05056509600093</udiDi>
    <basicUdiDi>B-05056509600093</basicUdiDi>
    <tradeName>ElisaRSR™TRAb 3rd Generation</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102100302</emdnCode>
    <emdnDescription>TSH RECEPTOR ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TRE/96/3A</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:22.710Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600086</udiDi>
    <basicUdiDi>B-05056509600086</basicUdiDi>
    <tradeName>ElisaRSR™TRAb 2nd Generation</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102100302</emdnCode>
    <emdnDescription>TSH RECEPTOR ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TRE/96/2A</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:21.815Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600079</udiDi>
    <basicUdiDi>B-05056509600079</basicUdiDi>
    <tradeName>ElisaRSR™ IA-2 Ab Version 2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102060106</emdnCode>
    <emdnDescription>THYROSIN PHOSPHATASE IA2 ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>IAE/96/2</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:20.935Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600062</udiDi>
    <basicUdiDi>B-05056509600062</basicUdiDi>
    <tradeName>ElisaRSR™ GAD Ab</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102060105</emdnCode>
    <emdnDescription>GAD II ANTIBODIES AND OTHER ICA</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GDE/96</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:20.047Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600055</udiDi>
    <basicUdiDi>B-05056509600055</basicUdiDi>
    <tradeName>ElisaRSR™ AQP4 Ab Version 2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102100299</emdnCode>
    <emdnDescription>NEURO-AUTO-IMMUNE DISEASE - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AQP4/96/2</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:19.115Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600048</udiDi>
    <basicUdiDi>B-05056509600048</basicUdiDi>
    <tradeName>ElisaRSR™ AChRAb</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102109022</emdnCode>
    <emdnDescription>ACETYLCHOLIN RECEPTOR ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ACE/96</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:18.216Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600031</udiDi>
    <basicUdiDi>B-05056509600031</basicUdiDi>
    <tradeName>ElisaRSR™ 21-OH Ab</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102109099</emdnCode>
    <emdnDescription>AUTO-IMMUNE DISEASE TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>21E/96/R</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:17.313Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600024</udiDi>
    <basicUdiDi>B-05056509600024</basicUdiDi>
    <tradeName>ElisaRSR™ 21-OH Ab</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102109099</emdnCode>
    <emdnDescription>AUTO-IMMUNE DISEASE TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>21E/96</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:16.418Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600017</udiDi>
    <basicUdiDi>B-05056509600017</basicUdiDi>
    <tradeName>ElisaRSR™ 3 Screen ICA™</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102060105</emdnCode>
    <emdnDescription>GAD II ANTIBODIES AND OTHER ICA</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3ZGI/96/R</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:15.510Z</lastUpdated>
  </row>
  <row>
    <udiDi>05056509600000</udiDi>
    <basicUdiDi>B-05056509600000</basicUdiDi>
    <tradeName>ElisaRSR™ 3 Screen ICA™</tradeName>
    <deviceName></deviceName>
    <manufacturerName>RSR Limited</manufacturerName>
    <manufacturerSrn>GB-MF-000025180</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102060105</emdnCode>
    <emdnDescription>GAD II ANTIBODIES AND OTHER ICA</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3ZGI/96</reference>
    <placedOnMarketCountry>Malta</placedOnMarketCountry>
    <lastUpdated>2026-06-19T15:23:14.636Z</lastUpdated>
  </row>
</eudamedExport>